NVCT Nuvectis Pharma, Inc. - Common Stock
$10,47
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 5, 2026
Zakres 52 tyg.
$6–$13
63% of range
Ocena Analityków
BUY
11 analysts
Cena Docelowa
$17
+60% upside
P/E (TTM)
-5.7
ROE
-149.9%
Marża Zysku Netto
—
NVCT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$10.47
Kapitalizacja Rynkowa
$194M
P/E (TTM)
-5.7
EPS (TTM)
$-1.32
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-149.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$6 – $13
NVCT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-1.32
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
NVCT
Mediana porównawcza
P/E (TTM)
-5.7
9.4
P/B
10.5
1.8
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
NVCT
Mediana porównawcza
ROA
-105.1%
-30.4%
ROE
-149.9%
-54.4%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
NVCT
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
2.4
3.8
Quick Ratio (Wskaźnik Szybkości)
2.4
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
NVCT
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
NVCT
Mediana porównawcza
NVCT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
11 analityków
- Mocne kupno 2 18,2%
- Kup 8 72,7%
- Trzymaj 1 9,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
5 analityków · 2026-05-14
Mediana
$18.00
Średnia
$16.80
Teraz
$10.47
Niski
$10.00
Wysoki
$20.00
Średni cel
$18.00
+71,9%
Średnia cel
$16.80
+60,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.02%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.26 | $-0.32 | 0.06% |
| 31 grudnia 2025 | $-0.31 | $-0.30 | -0.01% |
| 30 września 2025 | $-0.33 | $-0.25 | -0.08% |
| 30 czerwca 2025 | $-0.30 | $-0.26 | -0.04% |
| 31 marca 2025 | $-0.27 | $-0.26 | -0.01% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| SABS | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $18M | $13M | $15M | $13M | $10M | |
| SG&A Expense | $9M | $7M | $8M | $6M | $3M | |
| Operating Income | $-28M | $-20M | $-23M | $-19M | $-13M | |
| Net Income | $-26M | $-19M | $-22M | $-19M | $-13M | |
| EPS (Basic) | $-1.32 | $-1.11 | $-1.43 | $-1.51 | $-3.02 | |
| EPS (Diluted) | $-1.32 | $-1.11 | $-1.43 | $-1.51 | $-3.02 | |
| Shares (Basic) | 21,812,716 | 17,113,169 | 15,556,655 | 12,657,651 | 4,268,285 | |
| Shares (Diluted) | 21,812,716 | 17,113,169 | 15,556,655 | 12,657,651 | 4,268,285 | |
| EBITDA | $-28M | $-20M | $-23M | · | · |
Bilans 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $19M | $19M | $20M | $6M | |
| Other Current Assets | $75.0K | $74.0K | $59.0K | $412.0K | $91.0K | |
| Current Assets | $32M | $19M | $19M | $20M | $6M | |
| Total Assets | $32M | $19M | $19M | $20M | $7M | |
| Accounts Payable | $6M | $2M | $3M | $3M | $1M | |
| Accrued Liabilities | $115.0K | $840.0K | $415.0K | $445.0K | $395.0K | |
| Current Liabilities | $13M | $9M | $7M | $6M | $2M | |
| Total Liabilities | $13M | $9M | $7M | $6M | $2M | |
| Paid-in Capital | $118M | $83M | $66M | $46M | $2M | |
| Retained Earnings | $-100M | $-73M | $-54M | $-32M | $-13M | |
| Stockholders' Equity | $18M | $10M | $12M | $14M | $-11M | |
| Liabilities + Equity | $32M | $19M | $19M | $20M | $7M | |
| Shares Outstanding | 25,676,798 | 19,495,683 | 17,418,886 | 15,190,720 | 4,505,514 |
Przepływy pieniężne 6
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $5M | $2M | $2M | |
| Operating Cash Flow | $-16M | $-12M | $-16M | $-14M | $-10M | |
| Investing Cash Flow | · | · | $0 | $0 | · | |
| Stock Issued | · | $12M | $5M | · | · | |
| Net Stock Activity | · | $12M | $5M | · | · | |
| Financing Cash Flow | $29M | $12M | $15M | $28M | $15M |
Rentowność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -105.1% | -100.6% | -112.5% | · | · | |
| ROE | -149.9% | -183.5% | -154.1% | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.1 | 2.7 | · | · | |
| Quick Ratio | 2.4 | 2.1 | 2.7 | · | · |
Wycena (TTM) 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-26M | $-19M | $-22M | $-19M | $-13M | |
| Market Cap | $194M | $105M | $145M | · | · | |
| P/E | -5.7 | -4.9 | -5.8 | -5.0 | · | |
| P/B | 10.5 | 10.9 | 11.9 | · | · | |
| P / Tangible Book | 10.5 | 10.9 | 11.9 | 7.7 | · | |
| P / Cash Flow | -12.1 | -8.6 | -9.1 | · | · | |
| Earnings Yield | -17.5% | -20.5% | -17.2% | -20.1% | · |
Rachunek zysków i strat 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $5M | $6M | $4M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $2M | $4M | $5M | $3M | |
| SG&A Expense | $2M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Operating Income | $-6M | $-8M | $-8M | $-7M | $-6M | $-6M | $-4M | $-5M | $-4M | $-7M | $-6M | $-6M | $-4M | $-7M | $-6M | $-4M | |
| Net Income | $-6M | $-7M | $-7M | $-6M | $-5M | $-6M | $-4M | $-4M | $-4M | $-7M | $-6M | $-6M | $-4M | $-7M | $-6M | $-4M | |
| EPS (Basic) | $-0.26 | $-0.31 | $-0.44 | $-0.30 | $-0.27 | $-0.36 | $-0.24 | $-0.26 | $-0.25 | $-0.41 | $-0.37 | $-0.38 | $-0.27 | $-0.49 | $-0.42 | $-0.28 | |
| EPS (Diluted) | $-0.26 | $-0.31 | $-0.44 | $-0.30 | $-0.27 | $-0.36 | $-0.24 | $-0.26 | $-0.25 | $-0.41 | $-0.37 | $-0.38 | $-0.27 | $-0.49 | $-0.42 | $-0.28 | |
| Shares (Basic) | 23,414,475 | -42,210,116 | 22,719,057 | 21,366,268 | 19,937,507 | -33,577,295 | 17,230,559 | 16,900,570 | 16,559,335 | -30,450,075 | 16,104,446 | 15,178,035 | 14,724,249 | -23,269,553 | 14,050,271 | 12,717,794 | |
| Shares (Diluted) | 23,414,475 | -42,210,116 | 22,719,057 | 21,366,268 | 19,937,507 | -33,577,295 | 17,230,559 | 16,900,570 | 16,559,335 | -30,450,075 | 16,104,446 | 15,178,035 | 14,724,249 | -23,269,553 | 14,050,271 | 12,717,794 | |
| EBITDA | $-6M | · | $-8M | $-7M | $-6M | · | $-4M | $-5M | $-4M | · | $-6M | $-6M | $-4M | · | $-6M | $-4M |
Bilans 13
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $32M | $35M | $27M | $30M | $19M | $17M | $18M | $19M | $19M | $22M | $25M | $15M | $20M | $24M | $14M | |
| Other Current Assets | $268.0K | $75.0K | $145.0K | $214.0K | $284.0K | $74.0K | $138.0K | $182.0K | $250.0K | $59.0K | $203.0K | $341.0K | $740.0K | $412.0K | $1M | $666.0K | |
| Current Assets | $25M | $32M | $36M | $27M | $30M | $19M | $17M | $18M | $20M | $19M | $22M | $25M | $16M | $20M | $25M | $14M | |
| Total Assets | $25M | $32M | $36M | $27M | $30M | $19M | $17M | $18M | $20M | $19M | $22M | $25M | $16M | $20M | $25M | $14M | |
| Accounts Payable | $5M | $6M | $6M | $5M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | $1M | |
| Accrued Liabilities | $36.0K | $115.0K | $65.0K | $2.0K | $865.0K | $840.0K | $282.0K | $310.0K | $486.0K | $415.0K | $158.0K | $571.0K | $156.0K | $445.0K | $738.0K | $790.0K | |
| Current Liabilities | $11M | $13M | $12M | $10M | $9M | $9M | $6M | $6M | $6M | $7M | $6M | $5M | $4M | $6M | $4M | $3M | |
| Total Liabilities | $11M | $13M | $12M | $10M | $9M | $9M | $6M | $6M | $6M | $7M | $6M | $5M | $4M | $6M | $4M | $3M | |
| Paid-in Capital | $120M | $118M | $116M | $102M | $100M | $83M | $78M | $75M | $72M | $66M | $64M | $62M | $48M | $46M | $46M | $31M | |
| Retained Earnings | $-106M | $-100M | $-92M | $-85M | $-79M | $-73M | $-67M | $-63M | $-58M | $-54M | $-48M | $-42M | $-36M | $-32M | $-25M | $-19M | |
| Stockholders' Equity | $14M | $18M | $24M | $17M | $21M | $10M | $11M | $13M | $14M | $12M | $17M | $20M | $12M | $14M | $20M | $12M | |
| Liabilities + Equity | $25M | $32M | $36M | $27M | $30M | $19M | $17M | $18M | $20M | $19M | $22M | $25M | $16M | $20M | $25M | $14M | |
| Shares Outstanding | 26,525,533 | 25,676,798 | 25,639,896 | 23,877,587 | 23,634,586 | 19,495,683 | 18,985,324 | 18,748,751 | 18,356,060 | 17,418,886 | 17,309,911 | 17,221,113 | · | 15,190,720 | 14,642,483 | 12,717,794 |
Przepływy pieniężne 6
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $950.0K | $1M | $482.0K | $559.0K | $510.0K | |
| Operating Cash Flow | $-7M | $-4M | $-4M | $-3M | $-4M | $-2M | $-2M | $-3M | $-4M | $-4M | $-3M | $-4M | $-5M | $-4M | $-4M | $-3M | |
| Investing Cash Flow | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | $2M | $2M | $5M | $901.0K | $1M | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $7.0K | $166.0K | $13M | $296.0K | $16M | $4M | $1M | $2M | $5M | $917.0K | $703.0K | $13M | $252.0K | $-131.0K | $14M | $-578.0K |
Rentowność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | · | -28.2% | -28.0% | -21.4% | · | -21.0% | -20.5% | -23.2% | · | -25.0% | -29.1% | -23.9% | · | -47.3% | -50.1% | |
| ROE | -34.4% | · | -42.6% | -43.1% | -30.5% | · | -30.0% | -27.0% | -31.7% | · | -31.7% | -35.9% | -30.2% | · | -57.7% | -62.1% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | · | 3.1 | 2.7 | 3.3 | · | 2.7 | 3.2 | 3.5 | · | 4.0 | 5.4 | 4.1 | · | 5.5 | 5.2 | |
| Quick Ratio | 2.2 | · | 3.1 | 2.6 | 3.2 | · | 2.7 | 3.1 | 3.4 | · | 4.0 | 5.3 | 3.9 | · | 5.3 | 5.0 |
Wycena (TTM) 7
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-25M | · | $-23M | $-20M | $-18M | · | $-19M | $-20M | $-20M | · | $-22M | $-19M | $-16M | · | $-17M | $-17M | |
| Market Cap | $205M | · | $154M | $178M | $231M | · | $119M | $119M | $151M | · | $223M | $275M | · | · | $104M | $142M | |
| P/E | -6.1 | · | -4.8 | -7.0 | -9.6 | · | -5.6 | -5.0 | -6.5 | · | -9.0 | -11.8 | -10.2 | · | -3.4 | -3.6 | |
| P/B | 14.4 | · | 6.4 | 10.6 | 11.0 | · | 10.9 | 9.5 | 10.7 | · | 13.4 | 13.5 | · | · | 5.1 | 12.4 | |
| P / Tangible Book | 14.4 | · | 6.4 | 10.6 | 11.0 | · | 10.9 | 9.5 | 10.7 | · | 13.4 | 13.5 | · | · | 5.1 | 12.4 | |
| P / Cash Flow | -31.5 | · | · | · | -55.3 | · | · | · | -34.5 | · | · | · | · | · | · | · | |
| Earnings Yield | -16.4% | · | -20.8% | -14.3% | -10.4% | · | -17.8% | -19.9% | -15.5% | · | -11.2% | -8.5% | -9.8% | · | -29.1% | -27.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-26M | $-19M | $-22M | $-19M | $-13M |
| Rozwodniony EPS | $-1.32 | $-1.11 | $-1.43 | $-1.51 | $-3.02 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.4 | 2.1 | 2.7 | — | — |
| Wskaźnik Szybkości | 2.4 | 2.1 | 2.7 | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.